J.P. Morgan analyst Lisa Gill maintained a Hold rating on Humana (HUM – Research Report) yesterday and set a price target of $257.00. The company’s shares closed yesterday at $280.06. Gill covers ...
Indianapolis-based Community Health Network is suing Humana for allegedly failing to reimburse it for 340B drugs provided to the payer's members, the Indianapolis Business Journal reported Nov. 11.